Composition for suppressing obesity
A composition and obesity technology, applied in the direction of drug combination, drug delivery, plant raw materials, etc., can solve the problems of side effects and drug resistance, concurrent malabsorption, obesity and other problems, and achieve good stability and unaffected immunity , suitable for long-term storage effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0034] In some of the embodiments of the present invention, preferably, the preparation method of the tablet of the composition comprises the following steps: poloxamer, spirulina, xylitol, citric acid, cross-linked polyvinylpyrrolidone, micronized silica gel and magnesium stearate are weighed according to the mass ratio of 84:7:1:2:8:0.5:0.5, mixed, and compressed into tablets to obtain tablets;
[0035] The preparation method of the granules of the composition comprises the following steps: poloxamer, spirulina, xylitol, citric acid, cross-linked polyvinylpyrrolidone, polyvinyl alcohol 6000 according to the mass ratio of 84:7:1:2 : 4:15 to weigh, mix, spray into absolute ethanol to moisten, extrude to make wet granules, and obtain granules after drying;
[0036] The preparation method of the capsule of the composition comprises the following steps: weighing poloxamer, spirulina, xylitol, citric acid, and cross-linked polyvinylpyrrolidone according to the mass ratio of 84:7:1...
Embodiment 1
[0042] Embodiment 1 preparation of oral solid preparation of composition for suppressing obesity
[0043] Experimental group: according to the composition of the experimental group in Table 1, each component was measured, and oral solid preparations were prepared according to the following steps.
[0044] (1) Preparation of tablets of the obesity-suppressing composition: poloxamer, spirulina, xylitol, citric acid, cross-linked polyvinylpyrrolidone, micronized silica gel and magnesium stearate in a mass ratio of 84:7: 1:2:8:0.5:0.5 were weighed, mixed, and tableted to obtain tablets of the obesity-suppressing composition.
[0045] (2) Preparation of granules of obesity-suppressing composition: poloxamer, spirulina, xylitol, citric acid, cross-linked polyvinylpyrrolidone, and polyvinyl alcohol 6000 in a mass ratio of 84:7:1:2 :4:15 to weigh, mix, spray into absolute ethanol for wetting, extrude with a 15-mesh sieve to make wet granules, evaporate the ethanol, shape and mix with...
Embodiment 2
[0054] Example 2 Evaluation of the application effect of the composition preparation for suppressing obesity
[0055] (1) Obesity model animals
[0056] According to the literature, the obesity model of miniature pigs was established. The method is briefly described as follows: Bama miniature pigs were fed with high-fat and high-sugar feed for 30 weeks, and compared with Bama miniature pigs fed with normal diet, the body shape index and CT scan fat content were measured. 1. Collect blood to detect biochemical indicators to determine the success of the obesity model.
[0057] (2) Stability investigation and application effect evaluation
[0058] Stability investigation: The oral solid preparations of the experimental group and the control group were subjected to accelerated experiments, placed under the conditions of temperature (40±2)°C and relative humidity (75±5)% for 6 months, observing their physical and chemical properties, and evaluating their stability The results are...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap